Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-23-021396
Filing Date
2023-03-28
Accepted
2023-03-28 16:16:26
Documents
2
Period of Report
2023-03-14

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 14251
2 EX-24 DOCUMENT attachment1.htm EX-24 2739
  Complete submission text file 0001209191-23-021396.txt   18675
Mailing Address 5 SYLVAN WAY SUITE 300 PARSIPPANY NJ 07054
Business Address 5401 WEST KENNEDY BOULEVARD SUITE 890 TAMPA FL 33609 813-553-6680
Pacira BioSciences, Inc. (Issuer) CIK: 0001396814 (see all company filings)

EIN.: 510619477 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O TELA BIO, INC. 1 GREAT VALLEY PARKWAY, SUITE 24 MALVERN PA 19355
Business Address
Ellis Ronald J. Jr. (Reporting) CIK: 0001790670 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-35060 | Film No.: 23769776